Literature DB >> 10882824

The metabolic fate of sucralose in rats.

J Sims1, A Roberts, J W Daniel, A G Renwick.   

Abstract

The fate of sucralose was investigated in rats following single intravenous or oral doses of 2-1000mg/kg. Following intravenous administration (2-20mg/kg) approximately 80% of the dose was eliminated in urine with 9-16% in the faeces. In contrast, only about 5% of oral doses (10-1000mg/kg) was recovered in the urine, indicating that sucralose is poorly absorbed from the intestinal tract. After both intravenous and oral administration, the radioactivity excreted in urine and faeces was mainly unchanged sucralose. Two minor radioactive urinary components were observed, which together accounted for less than 1% of the administered dose. Rats which had been given high concentrations of sucralose (3%) in the diet for more than 18 months showed a similar metabolic profile, demonstrating that metabolic adaptation of the gut microflora or mammalian enzymes had not occurred during the treatment period.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882824     DOI: 10.1016/s0278-6915(00)00034-x

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  14 in total

1.  Male rats show an indifference-avoidance response for increasing concentrations of the artificial sweetener sucralose.

Authors:  Nicholas T Bello; Andras Hajnal
Journal:  Nutr Res       Date:  2005-07       Impact factor: 3.315

Review 2.  Sweet taste receptor in the hypothalamus: a potential new player in glucose sensing in the hypothalamus.

Authors:  Daisuke Kohno
Journal:  J Physiol Sci       Date:  2017-04-04       Impact factor: 2.781

3.  Rapid stimulus-bound suppression of intake in response to an intraduodenal nonnutritive sweetener after training with nutritive sugars predicting malaise.

Authors:  Lindsey A Schier; Terry L Davidson; Terry L Powley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

4.  Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.

Authors:  Maliha Shaikh; Kumar Rajan; Christopher B Forsyth; Robin M Voigt; Ali Keshavarzian
Journal:  Clin Chim Acta       Date:  2015-01-12       Impact factor: 3.786

5.  Sucralose administered in feed, beginning prenatally through lifespan, induces hematopoietic neoplasias in male swiss mice.

Authors:  Soffritti M; Padovani M; Tibaldi E; Falcioni L; Manservisi F; Lauriola M; Bua L; Manservigi M; Belpoggi F
Journal:  Int J Occup Environ Health       Date:  2016-01-29

6.  Rationale for further medical and health research on high-potency sweeteners.

Authors:  Susan S Schiffman
Journal:  Chem Senses       Date:  2012-04-26       Impact factor: 3.160

7.  Sugar substitutes: Health controversy over perceived benefits.

Authors:  Kirtida R Tandel
Journal:  J Pharmacol Pharmacother       Date:  2011-10

8.  Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.

Authors:  Puneet Bagga; Mohammad Haris; Kevin D'Aquilla; Neil E Wilson; Francesco M Marincola; Mitchell D Schnall; Hari Hariharan; Ravinder Reddy
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

Review 9.  Sucralose, a synthetic organochlorine sweetener: overview of biological issues.

Authors:  Susan S Schiffman; Kristina I Rother
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

Review 10.  Sucralose Non-Carcinogenicity: A Review of the Scientific and Regulatory Rationale.

Authors:  Colin Berry; David Brusick; Samuel M Cohen; Jerry F Hardisty; V Lee Grotz; Gary M Williams
Journal:  Nutr Cancer       Date:  2016-09-21       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.